COVID-19 Resources and Services from WCG:
COVID-19 Webinar Series
Watch the WCG COVID-19 Webinar Series On-Demand
Join thousands of your peers in watching WCG’s webinar series, where clinical trial and public health experts provide the insights on COVID-19 and discuss the biggest questions and topics you submit.
COVID-19 Clinical Trial Tracker
Monitor the progress of clinical trials for COVID-19 treatments and vaccines, leveraging data from the WCG Knowledge Base™.
COVID-19 Trial Insights from the WCG Knowledge Base™
About WCG Trial Insights
The WCG Trial Insights series brings you weekly insights on trial activity throughout the COVID-19 crisis, based on the extensive services we provide to life science clients and supported by our proprietary and powerful WCG Knowledge Base™.
WCG COVID-19 Advisory Services
Need help interpreting critical data to navigate the impact of COVID-19 on trials and sites? We leverage insights and benchmark data from the WCG Knowledge Base to guide best practices for trial performance during this unprecedented time.
Insights from June 11, 2021
Recent Insights from WCG
The map below displays WCG locations. The same locations are listed below the map.
Watch Recent COVID-19 Webinars
Recent news on COVID-19 and clinical trials
News provided by WCG FDAnews and WCG CenterWatch
Walensky Endorses CDC Panel Greenlight for Moderna, J&J Booster Vaccinations, and Mix and Match
Last month, Walensky overrode the recommendations of the advisory committee, which supported a Pfizer/BioNTech COVID-19 booster, but not for adults at high risk of contracting the disease in the workplace.
UK Lists Nerve Disorder as Rare Side Effect of AstraZeneca COVID-19 Shot
Guillain-Barré syndrome affects the body’s immune system and damages nerve cells, causing muscle weakness and in some cases paralysis.
CDC Gives Thumbs Up to Moderna and J&J COVID-19 Boosters, and Mixing and Matching Vaccines
Moderna’s and Johnson & Johnson’s COVID-19 boosters, along with mixing and matching of shots, was greenlighted unanimously by scientific advisers to the Centers for Disease Control and Prevention (CDC) on Thursday, just after FDA approved the two boosters for limited populations.
FDA Authorizes ‘Mix and Match’ Approach, Moderna and J&J COVID-19 Boosters
The FDA yesterday authorized boosters of both the Moderna and Johnson & Johnson (J&J) COVID-19 vaccines for emergency use. The agency also authorized a “mix and match” approach for emergency use that allows people to receive a booster with a different drugmaker’s product to the one they received in their…
White House Secures 28 Million Pfizer COVID-19 Vaccine Doses for Kids in Advance of FDA and CDC Approvals
The White House has secured 28 million doses of the Pfizer-BioNTech pediatric COVID-19 vaccine and plans to roll out the jabs for kids age five to 11 as soon as the FDA and Centers for Disease Control and Prevention (CDC) give the go-ahead for vaccines in that age group.
Gates Foundation Pledges $120 Million to Speed Generic Production of Merck’s COVID-19 Pill
Since the pandemic began, the Gates Foundation has previously spent $1.9 billion to support research and development and manufacturing efforts for COVID-19 vaccines, drugs and tests.
FDA Set to Authorize Moderna, J&J COVID-19 Boosters
The FDA is poised to authorize booster shots of Moderna’s and Johnson & Johnson’s COVID-19 vaccines and may also allow a “mix and match” approach.
Interferon Doesn’t Improve Outcomes for Hospitalized Adults With COVID-19
For the cohort of participants needing high-flow oxygen, interferon beta-1a alone was also associated with more serious side effects, specifically, worsening respiratory responses, NIH said.
EMA Reviews Pfizer/BioNTech COVID-19 Vaccine for Children Ages 5 to 11
The EMA has approved two more Pfizer/BioNTech finished-product manufacturing sites in Italy.
Valneva’s COVID-19 Jab Elicits Better Immunity Than AstraZeneca’s in Clinical Trial
AZD1222, which is not authorized in the U.S., is currently approved for use in the UK and EU, while Valneva is not yet approved for use anywhere.
Dozens of Lawsuits Seek to Make Hospitals Give Ivermectin to COVID-19 Patients
Lawsuits seeking to force hospitals to administer ivermectin to COVID-19 patients show no signs of slowing in recent weeks — despite repeated warnings by regulators against such use.
FDA Expert Panel Unanimously Greenlights J&J’s COVID-19 Booster
A day after its unanimous vote in favor of Moderna’s COVID-19 booster shot, a panel of vaccine experts that advises the FDA also voted unanimously to grant Johnson & Johnson’s (J&J) COVID-19 booster shot Emergency Use Authorization (EUA).
Expert insights on clinical trials and COVID-19
As we navigate COVID-19 together, our clinical trial experts are engaged to address the biggest questions. To submit a topic or question, use the form at the bottom of the page.
Submit a COVID-19 question or topic to be considered in future webinars
Please note: protocol-specific questions for studies under the oversight of a WCG IRB should be submitted through your IRB contact person, not through this form.
Disclaimer: All information available on this site is intended for your general knowledge and is not for the purpose of providing regulatory advice, medical advice, or a substitute for institutional review board review. You should not use this information to determine compliance with any applicable laws or regulations governing institutional review boards and human subjects research.